Published in Biotech Law Weekly, February 23rd, 2007
Under the terms of the agreement, PRL will provide price incentives for safety and efficacy laboratory testing, toxicological testing, and employee health screening services to KansasBio and its member companies.
It typically takes close to 10 years and nearly one billion dollars to test a new drug or device for commercial application. PRL plays a critical role in the process by testing the safety of the drug or device as it affects the patient during clinical trials. The data generated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.